European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

類似資料

• Allogeneic hematopoietic cell transplant for normal karyotype acute myeloid leukemia: Indirect evidence of selection for adverse molecular profile
  著者:: Percival, Mary-Elizabeth M., 等
  出版事項: (2015)
• Adoptive Immunotherapy with Cytokine Induced Killer Cells For Patients with Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
  著者:: Laport, Ginna G., 等
  出版事項: (2011)
• Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation
  著者:: Muffly, Lori, 等
  出版事項: (2018)
• Validation of the Hematopoietic Cell Transplantation–Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation
  著者:: Veeraputhiran, Muthu, 等
  出版事項: (2017)
• Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
  著者:: Naik, S, 等
  出版事項: (2010)